BIOG-B.ST

BioGaia AB (publ) [BIOG-B.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIOG-B.ST Stock Summary

Top 10 Correlated ETFs

BIOG-B.ST

Top 10 Correlated Stocks

BIOG-B.ST

In the News

BIOG-B.ST Financial details

Company Rating
-
Market Cap
11.27B
Income
365.35M
Revenue
1.3B
Book val./share
-
Cash/share
-
Dividend
1.45
Dividend %
1.38%
Employees
210
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
24.31
Forward P/E
-
PEG
-128.5
P/S
8.05
P/B
5.36
P/C
-
P/FCF
28.78
Quick Ratio
6.68
Current Ratio
8.44
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.63
EPS next Y
-
EPS next Q
-
EPS this Y
-2.16%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.88%
Revenue last 5Y
11.03%
Revenue Q/Q
-6.27%
EPS Q/Q
-33.66%
-
-
-
-
SMA20
-8.18%
SMA50
-22.31%
SMA100
-4.72%
Inst Own
-
Inst Trans
-
ROA
19%
ROE
22%
ROC
0.25%
Gross Margin
73%
Oper. Margin
40%
Profit Margin
34%
Payout
67%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
91.2-135.6
52W High
-24.07%
52W Low
+12.64%
RSI
47
Rel Volume
0.69
Avg Volume
120.68K
Volume
82.78K
Perf Week
0.59%
Perf Month
-11.33%
Perf Quarter
-6.99%
Perf Half Y
-1.44%
-
-
-
-
Beta
0.539
-
-
Volatility
1.15%, 5.69%
Prev Close
0%
Price
102.5
Change
2.6%

BIOG-B.ST Financial Performance

BIOG-B.ST Dividend History

BIOG-B.ST Frequently Asked Questions

What is BioGaia AB (publ) stock symbol ?

BioGaia AB (publ) is a SE stock and trading under the symbol BIOG-B.ST

What is BioGaia AB (publ) stock quote today ?

BioGaia AB (publ) stock price is $102.5 today.

Is BioGaia AB (publ) stock public?

Yes, BioGaia AB (publ) is a publicly traded company.

Something similar

Top by Market Cap
3V64.DE
GOOGL
FXAIX
MIX.JO
NVD.DE
Top Correlated ETFs
EHLT.DE
ESIH.DE
LHTC.DE
SPYH.DE
EXV4.DE
Top Correlated Stocks
SAN.PA
SNW.DE
ZEG.DE
AZN.L
ARJO-B.ST
Similar Market Cap
ADSL.NS
002482.SZ
FMC
600452.SS
CCK

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 120.68K
  • Market Capitalization 11.27B
  • Employee 210
  • CEO Ms. Theresa P. Agnew
  • Headquarters Stockholm,SE
  • IPO Date 2000-01-03
  • Website https://www.biogaia.com

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.